These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10500563)

  • 21. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 24. Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy.
    Rostaing L; Tran-Van T; Cisterne JM; Tack I; Durand D; Ader JL
    Transplant Proc; 1998 Jun; 30(4):1279-81. PubMed ID: 9636519
    [No Abstract]   [Full Text] [Related]  

  • 25. Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.
    Diekmann F; Waiser J; Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2001; 33(7-8):3234-5. PubMed ID: 11750386
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
    Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
    [No Abstract]   [Full Text] [Related]  

  • 27. Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney-pancreas transplant recipient.
    Bakri R; Breen C; Maclean D; Taylor J; Goldsmith D
    Transpl Int; 2003 Jun; 16(6):441-3. PubMed ID: 12819878
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
    Shapiro R; Jordan ML; Scantlebury VP; Fung JJ; Jensen C; Vivas C; McCauley J; Irish WD; Mitchell S; Demetris AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):669-72. PubMed ID: 7679836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
    Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
    Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
    Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug interaction between tacrolimus and ertapenem in renal transplantation recipients.
    Bora F; Aliosmanoglu I; Kocak H; Dinckan A; Uslu HB; Gunseren F; Suleymanlar G
    Transplant Proc; 2012 Dec; 44(10):3029-32. PubMed ID: 23195020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
    Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
    Morales JM; Andres A; Rengel M; Rodicio JL
    Nephrol Dial Transplant; 2001; 16 Suppl 1():121-4. PubMed ID: 11369839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients.
    Rostaing L; Tran-Van T; Cisterne JM; Tack I; Durand D; Ader JL
    Transplant Proc; 1998 Jun; 30(4):1282-4. PubMed ID: 9636520
    [No Abstract]   [Full Text] [Related]  

  • 38. Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.
    Morris-Stiff G; Singh J; Balaji V; Ostrowski K; Webley Y; Moore R; Lord R; Jurewicz WA
    Transplant Proc; 1998 Jun; 30(4):1230-1. PubMed ID: 9636499
    [No Abstract]   [Full Text] [Related]  

  • 39. FK 506 in the management of nephrotic syndrome after renal transplantation.
    McCauley J; Shapiro R; Jordan M; Scantlebury V; Vivas C; Jensen C; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1351-4. PubMed ID: 7680154
    [No Abstract]   [Full Text] [Related]  

  • 40. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.